Induction Therapy in Simultaneous Pancreas-Kidney Transplantation: Thymoglobulin Versus Basiliximab

Abstract Background Induction therapy for simultaneous pancreas-kidney (SPK) transplantation. Both thymoglobulin (ATG) and basiliximab are the most-used types of induction antibodies therapies in clinical practice. The aim of our report was to analyze our experience comparing 2 induction therapies,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation proceedings 2015, Vol.47 (1), p.120-122
Hauptverfasser:	Fernández-Burgos, I, Montiel Casado, M.C, Pérez-Daga, J.A, Aranda-Narváez, J.M, Sánchez-Pérez, B, León-Díaz, F.J, Cabello-Díaz, M, Rodríguez-Burgos, D, Hernández-Marrero, D, Santoyo-Santoyo, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal - therapeutic use Antilymphocyte Serum - therapeutic use Female Graft Rejection Graft Survival HLA Antigens - analysis Humans Immunosuppressive Agents - therapeutic use Induction Chemotherapy - methods Kidney Transplantation - mortality Length of Stay Male Middle Aged Multivariate Analysis Pancreas Transplantation - mortality Postoperative Complications - epidemiology Recombinant Fusion Proteins - therapeutic use Retrospective Studies Surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!